Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

161 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MASCC multidisciplinary evidence-based recommendations for the management of malignant bowel obstruction in advanced cancer.
Madariaga A, Lau J, Ghoshal A, Dzierżanowski T, Larkin P, Sobocki J, Dickman A, Furness K, Fazelzad R, Crawford GB, Lheureux S. Madariaga A, et al. Among authors: lheureux s. Support Care Cancer. 2022 Jun;30(6):4711-4728. doi: 10.1007/s00520-022-06889-8. Epub 2022 Mar 10. Support Care Cancer. 2022. PMID: 35274188 Free PMC article.
Malignant Bowel Obstruction in Advanced Gynecologic Cancers: An Updated Review from a Multidisciplinary Perspective.
Lee YC, Jivraj N, O'Brien C, Chawla T, Shlomovitz E, Buchanan S, Lau J, Croke J, Allard JP, Dhar P, Laframboise S, Ferguson SE, Dhani N, Butler M, Ng P, Stuart-McEwan T, Savage P, Tinker L, Oza AM, Lheureux S. Lee YC, et al. Among authors: lheureux s. Obstet Gynecol Int. 2018 May 17;2018:1867238. doi: 10.1155/2018/1867238. eCollection 2018. Obstet Gynecol Int. 2018. PMID: 29887891 Free PMC article. Review.
Optimizing the Care of Malignant Bowel Obstruction in Patients With Advanced Gynecologic Cancer.
Lee YC, Jivraj N, Wang L, Chawla T, Lau J, Croke J, Allard JP, Stuart-McEwan T, Nathwani K, Bowering V, Karakasis K, O'Brien C, Shlomovitz E, Ferguson SE, Buchanan S, Ng P, Cyriac S, Tinker L, Dhani N, Oza AM, Lheureux S. Lee YC, et al. Among authors: lheureux s. J Oncol Pract. 2019 Dec;15(12):e1066-e1075. doi: 10.1200/JOP.18.00793. Epub 2019 Sep 24. J Oncol Pract. 2019. PMID: 31550202 Free PMC article.
EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression.
Lheureux S, Oaknin A, Garg S, Bruce JP, Madariaga A, Dhani NC, Bowering V, White J, Accardi S, Tan Q, Braunstein M, Karakasis K, Cirlan I, Pedersen S, Li T, Fariñas-Madrid L, Lee YC, Liu ZA, Pugh TJ, Oza AM. Lheureux S, et al. Clin Cancer Res. 2020 Aug 15;26(16):4206-4215. doi: 10.1158/1078-0432.CCR-19-4121. Epub 2020 May 22. Clin Cancer Res. 2020. PMID: 32444417 Clinical Trial.
Adjuvant treatment in early stage cervical cancer-does more equal better?
Madariaga A, Kasherman L, Han K, Lheureux S, Oza AM. Madariaga A, et al. Among authors: lheureux s. Int J Gynecol Cancer. 2020 Sep;30(9):1467-1468. doi: 10.1136/ijgc-2020-001840. Epub 2020 Jul 20. Int J Gynecol Cancer. 2020. PMID: 32690593 No abstract available.
New approaches for targeting platinum-resistant ovarian cancer.
McMullen M, Madariaga A, Lheureux S. McMullen M, et al. Among authors: lheureux s. Semin Cancer Biol. 2021 Dec;77:167-181. doi: 10.1016/j.semcancer.2020.08.013. Epub 2020 Aug 29. Semin Cancer Biol. 2021. PMID: 32871277 Review.
161 results